| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/30/2013 | US20130137096 Diagnosis of Hereditary Spastic Paraplegias (HSP) by Identification of a Mutation in the ZFVYE26 Gene or Protein |
| 05/30/2013 | US20130137092 Device for detecting and separating target molecules and method for detecting and separating target molecules by using the same |
| 05/30/2013 | US20130137088 Factor involved in latent infection with herpesvirus, and use thereof |
| 05/30/2013 | US20130137085 Method for Real-Time Measurement of the Individual Secretions of a Cell |
| 05/30/2013 | US20130137083 Detection of H5N1 Influenza Infection |
| 05/30/2013 | US20130136760 Streptococcus pyogenes antigens and corresponding dna fragments |
| 05/30/2013 | US20130136755 Mlk4 gene, a new diagnostic and prognostic marker in cancers |
| 05/30/2013 | US20130136753 Paxillin as a therapeutic or diagnostic marker for cancer |
| 05/30/2013 | US20130136747 Anti-amyloid beta antibodies and their use |
| 05/30/2013 | US20130136745 Soluble endoglin and uses thereof |
| 05/30/2013 | US20130136689 Proteins |
| 05/30/2013 | US20130136656 Exhaust gas measurement device and recording medium having program for exhaust gas measurement device recorded thereon |
| 05/30/2013 | US20130134367 Electric insulating oil inspection method, electric insulating oil treatment method, and oil-filled electric device maintenance method |
| 05/30/2013 | US20130133586 Fuidi herd management schema |
| 05/30/2013 | US20130133407 Methods For Analysis Of Water And Substrates Rinsed In Water |
| 05/30/2013 | US20130133406 Device for measuring a composition of a fuel mixture |
| 05/30/2013 | US20130133400 Device for measuring at least one exhaust gas component in an exhaust gas duct of a combustion process |
| 05/30/2013 | CA2856881A1 Versatile and sensitive biosensor |
| 05/30/2013 | CA2856867A1 Methods for producing retinal tissue and retina-related cell |
| 05/30/2013 | CA2856866A1 Administration of alpha4beta7 hetero-dimer-specific antibody |
| 05/30/2013 | CA2856399A1 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| 05/30/2013 | CA2856382A1 Devices containing dried reagents for reconstitution as calibration and/or quality control solutions, and methods of production and use thereof |
| 05/30/2013 | CA2856297A1 Binding molecules specific for her3 and uses thereof |
| 05/30/2013 | CA2856269A1 Method for detecting the presence of bubbles during operations of injecting resin for the manufacture of fibre composite components |
| 05/30/2013 | CA2856258A1 Monoclonal antibodies specific for the m2-1 antigen of respiratory syncytial virus (rsv) |
| 05/30/2013 | CA2856252A1 Methods of treating psoriatic arthritis (psa) using il-17 antagonists and psa response or non-response alleles |
| 05/30/2013 | CA2855699A1 Anti-human trop-2 antibody having an antitumor activity in vivo |
| 05/30/2013 | CA2855139A1 Fibrinogen assay |
| 05/30/2013 | CA2854921A1 Methods of treatment using an antibody against interferon gamma |
| 05/30/2013 | CA2854857A1 Monoclonal antibody for the detection of snap/clip tag |
| 05/30/2013 | CA2854255A1 Mutations of histone proteins associated with proliferative disorders |
| 05/30/2013 | CA2853812A1 Signal amplification in lateral flow and related immunoassays |
| 05/30/2013 | CA2852600A1 Symmetrical test element for detecting an analyte |
| 05/30/2013 | CA2797519A1 Tracers for detecting the presence of solid admixtures |
| 05/30/2013 | CA2796684A1 Aircraft screening device and method |
| 05/29/2013 | EP2597468A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 05/29/2013 | EP2597467A1 Means and methods for proSP-B based diagnosis of pulmonary congestion in ACS patients |
| 05/29/2013 | EP2597466A1 Means and methods for proSP-B based diagnosis of alveolar damage in pulmonary hypertension patients |
| 05/29/2013 | EP2597465A1 TnT and H-FABP for diagnosis of cardiac damage in infection |
| 05/29/2013 | EP2597464A2 Metabolomic profiling of prostate cancer |
| 05/29/2013 | EP2597463A1 Methods of enrichment and isolation of regulatory T-cells and use of the same |
| 05/29/2013 | EP2597462A1 Symmetrical test element for detecting an analyte |
| 05/29/2013 | EP2597461A2 Process for directly measuring multiple biodegradabilities |
| 05/29/2013 | EP2597453A2 Load measuring device and method for mechanical load testing |
| 05/29/2013 | EP2597161A2 Method of manufacturing micro chamber plate with built-in sample and analytic micro chamber plate, analytic micro chamber plate and apparatus set for manufacturing analytic micro chamber plate with built-in sample |
| 05/29/2013 | EP2597158A1 Method for quantifying the amount of cholesterol in high-density lipoprotein 3 |
| 05/29/2013 | EP2597151A2 Recombinant microorganisms, methods for preparing vaccine strains, antigens, and vector vaccine compositions of same, uses thereof, and related antibodies, diagnostic kit, and treatment and/or prophylactic methods |
| 05/29/2013 | EP2596975A1 Identification and security device using short-distance ocular biometry |
| 05/29/2013 | EP2596799A1 Methods and compositions related to inhibition of viral entry |
| 05/29/2013 | EP2596370A1 Magnetic immunodiagnostic methods and kits for the demonstration of antibody/antigen complexes in erythrocyte blood grouping and phenotyping |
| 05/29/2013 | EP2596369A2 Mass spectrometric methods for quantifying npy 1-36 and npy 3-36 |
| 05/29/2013 | EP2596368A2 Improving the efficiency of prion conversion in vitro and sensitivity of prion detection |
| 05/29/2013 | EP2596367A1 Competition assay |
| 05/29/2013 | EP2596365A2 Monoclonal antibodies against pcbp-1 antigens, and uses therefor |
| 05/29/2013 | EP2596364A1 Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancer |
| 05/29/2013 | EP2596363A1 Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |
| 05/29/2013 | EP2596362A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 05/29/2013 | EP2596361A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 05/29/2013 | EP2596360A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 05/29/2013 | EP2596359A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 05/29/2013 | EP2596358A1 Method to identify a patient with an increased likelihood of responding to an anti-cancer therapy |
| 05/29/2013 | EP2596357A2 Diagnostic reagents |
| 05/29/2013 | EP2596356A1 Method of performing an assay |
| 05/29/2013 | EP2596355A2 Methods for isolating and using a subset of cd8 t-cells that are resistant to cyclosporin |
| 05/29/2013 | EP2596354A2 Co-coupling to control reactivity of reagents in immunoassays |
| 05/29/2013 | EP2596353A1 Methods of detecting prenatal or pregnancy-related diseases or conditions |
| 05/29/2013 | EP2596352A2 Systems and methods for detection of cellular stress |
| 05/29/2013 | EP2596351A1 Method and device for analysing molecular interactions, and uses thereof |
| 05/29/2013 | EP2596350A1 Apparatus and method for the automated detection of phases for automated analysis |
| 05/29/2013 | EP2596349A2 Methods of detecting cardiovascular diseases or conditions |
| 05/29/2013 | EP2596348A1 System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (tcpp) |
| 05/29/2013 | EP2596346A1 Automated analysis of pressurized reservoir fluids |
| 05/29/2013 | EP2596343A2 Biosensor apparatuses and methods thereof |
| 05/29/2013 | EP2596335A2 Chemical and physical degradation sensing in oil |
| 05/29/2013 | EP2596331A1 Method and device for detecting trace amounts of many gases |
| 05/29/2013 | EP2596136A1 Marker consisting of plasma microrna and new method for diagnosis of hepatocellular carcinoma |
| 05/29/2013 | EP2596134A2 Methods of detecting diseases or conditions using phagocytic cells |
| 05/29/2013 | EP2596133A2 Methods of detecting neurological or neuropsychiatric diseases or conditions |
| 05/29/2013 | EP2596132A2 Methods for detecting signatures of disease or conditions in bodily fluids |
| 05/29/2013 | EP2596127A2 Identification of differentially represented fetal or maternal genomic regions and uses thereof |
| 05/29/2013 | EP2596126A1 Methods for determining a prognosis for survival for a patient with leukaemia |
| 05/29/2013 | EP2596125A1 In vivo method for the evaluation of a compound-target interaction |
| 05/29/2013 | EP2596122A2 Modulators for sirt5 and assays for screening same |
| 05/29/2013 | EP2596121A2 Method for linking point of care rapid diagnostic testing results to laboratory-based methods |
| 05/29/2013 | EP2596119A2 Methods for detection of rare subpopulations of cells and highly purified compositions of cells |
| 05/29/2013 | EP2596117A2 Methods of detecting kidney-associated diseases or conditions |
| 05/29/2013 | EP2596116A2 Methods of detecting autoimmune or immune-related diseases or conditions |
| 05/29/2013 | EP2596115A1 Zwitterion buffer containing compositions and uses in electroanalytical devices and methods |
| 05/29/2013 | EP2596096A1 Method for inducing differentiation of human pluripotent stem cell into intermediate mesoderm cell |
| 05/29/2013 | EP2596065A2 Luminescent dyes with a water-soluble intramolecular bridge and their biological conjugates |
| 05/29/2013 | EP2596025A1 Methods for cancer management targeting co-029 |
| 05/29/2013 | EP2596010A2 Signal biomarkers |
| 05/29/2013 | EP2595752A1 Method for hydrophilizing surfaces of fluidic components and parts containing such components |
| 05/29/2013 | EP2595714A1 Sound-velocity dewatering system |
| 05/29/2013 | EP2595645A2 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom |
| 05/29/2013 | DE102012013999A1 Gas admission device for testing operability and calibration of gas measuring instruments, has a test chamber device connected to main pipes such that calibration gas and zero-point gas in pipes are fed time-sequentially in a row |
| 05/29/2013 | DE102012008274A1 Gasbeaufschlagungs-Vorrichtung für Gasmessgeräte, Verfahren zum Prüfen von Gas-Messgeräten sowie Kalibrierungsmessgerät zum Prüfen und Kalibrieren von Gasmessgeräten Gasbeaufschlagungs device for gas detection instruments, methods for testing gas measuring instruments and calibration instrument for testing and calibration of gas detectors |
| 05/29/2013 | DE102011119484A1 Membran zur Bestimmung von Gasen in nicht wässrigen Flüssigkeiten, Verfahren zur Herstellung der Membran, Messanordung und Verfahren zu Bestimmung von Gasen in nicht wässrigen Flüssigkeiten Membrane for the determination of gases in non-aqueous liquids, processes for preparing the membrane, measurement arrangement and method for the determination of gases in non-aqueous liquids |
| 05/29/2013 | CN202956447U Smoke sensing test tool for high voltage frequency converter |
| 05/29/2013 | CN202956385U Test paper used for detecting florfenicol and thiamphenicol |